About this trial

This is an observational mono-institutional study. Patients with gynecologic tumors treated with advanced radiotherapy- Image Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Body Radiotherapy (SBRT)- will be included and toxicity and outcomes analyzed.

Eligibility criteria

Qualifiers

gynecologic cancer patients

>18 years old

treated with advanced radiotherapy techniques (IGRT, IMRT, SBRT)

Disqualifiers

other tumors

> 90 years old

Trial design

Treatments tested in this trial

  • Image Guided Radiotherapy

Treatment groups

1,000 Participants
are divided into 1 treatment group

Locations

1
San Raffaele Scientific Institute20132, MilanMI, Italy

Sponsors and collaborators

IRCCS San Raffaele

Lead sponsor